-
bluebird bio jobs
Total searched jobs are :213657
-
Senior Medical Science Liaison - Gene Therapy, North Central
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-26-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-25-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-25-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-25-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-25-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-25-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-25-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-25-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-25-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-25-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-25-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-24-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-24-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-24-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-24-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-22-2021
-
Senior Medical Science Liaison (Sr. MSL), Gene Therapy, Northeast
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-22-2021
-
Senior Medical Science Liaison - Gene Therapy, North Central
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 07-08-2021
-
Senior Medical Science Liaison (Sr. MSL) - Gene Therapy, West Region
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 06-24-2021
-
Senior Medical Science Liaison (Sr. MSL) - Gene Therapy, West Region
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncolo ...Read More
Posted: 06-24-2021
Search for us bluebird bio jobs Save search criteria
Filter Results By:
- Refinements:
-